RxDoctor Payments Data

Kayla Hopkins

Physician Assistant · Burbank, CANPI 1114641545

Payments from drug & device makers

$2,875in general payments, 2019–2025

Across 111 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$483
  • AstraZeneca$415
  • Sanofi$331
  • Regeneron Healthcare Solutions, Inc.$327
  • Takeda Pharmaceuticals U.S.A., Inc.$274
  • Novartis$252
  • plus $793 from 14 others

What the payments were for

  • Food & beverage$2,875100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,875 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,362
Spiriva RespimatTiotropium Bromide31$20,470
XhanceFluticasone Propionate14$14,069
Epinephrine34$7,217
Incruse ElliptaUmeclidinium Bromide19$6,505
BreynaBudesonide/Formoterol Fumarate22$4,549
Arnuity ElliptaFluticasone Furoate12$3,251
Azelastine Hcl121$2,369
Fluticasone Propionate116$1,262
Albuterol Sulfate HfaAlbuterol Sulfate27$1,098
Ipratropium Bromide42$1,056
Tacrolimus12$985
Desloratadine36$909
Olopatadine Hcl22$876
Ventolin HfaAlbuterol Sulfate13$722

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSpiriva Respimat$27$20,47031 claims
Optinose US, Inc.Xhance$24$14,06914 claims
GSKIncruse Ellipta, Arnuity Ellipta$483$9,75631 claims
Hikma Pharmaceuticals USAEpinephrine$22$7,21734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Burbank

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →